Humacyte, Inc. Common Stock

HUMANASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
0.56 USD
↘ 0.01 (1.16%)AT CLOSE (11:59 AM EDT)
0.57
↗ 0.01 (0.89%)
POST MARKET (AS OF 07:53 PM EDT)
Post Market
AS OF 07:53 PM EDT
0.57
↗ 0.01 (0.89%)
🔴Market: CLOSED

Shares of Humacyte, Inc. Common Stock (HUMA) are trading at $0.57. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, HUMA trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Sep 14, 2026.

Open?$0.55
High?$0.57
Low?$0.55
Prev. Close?$0.57
Volume?3.2M
Avg. Volume?7.8M
VWAP?$0.56
Rel. Volume?0.41x
Bid / Ask
Bid?$0.48 × 100
Ask?$0.64 × 100
Spread?$0.16
Midpoint?$0.56
Valuation & Ratios
Market Cap?158.3M
Shares Out?277.8M
Float?245.5M
Float %?88.4%
P/E Ratio?N/A
P/B Ratio?5.07
EPS?-$0.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Themes
Biotech - Drug Development›Clinical-Stage Platforms
Employees
184
Market Cap
157.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.humacyte.com
Listed
2021-08-27
Address
2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM, NC 27713
Phone: 919-313-9633
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
57
Short Sent.?
45
Piotroski F-Score?4/9Mixed
Altman Z-Score?-9.06Distress
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.14%High
Short Interest?29.8M
Days to Cover?3.4
Free Float245.5M
Avg Daily Volume8.8M
Settlement Date2026-08-31
Financial Health
Current Ratio?6.21Strong
Quick Ratio?5.74Strong
Cash Ratio?5.35Strong
Debt/Equity?2.12High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
36
5.07FAIR▾
P/S?
Peers
100
S&P
3
74.66HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.3CHEAP▾
EV/Sales?
Peers
100
S&P
3
68.19HIGH▾
Returns & Efficiency
ROE?
S&P
3
-309.4%WEAK▾
ROA?
S&P
3
-70.1%WEAK▾
Cash Flow & Enterprise
FCF?$-97560000
Enterprise Value?$144.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist